<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="38747">Taxifolin</z:chebi> has been widely used in the treatment of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> and sequelae, <z:e sem="disease" ids="C0936263" disease_type="Disease or Syndrome" abbrv="">cerebral thrombus</z:e>, <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> and <z:hpo ids='HP_0001681'>angina pectoris</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A reliable sensitive reversed-phase high-performance liquid chromatography (RP-HPLC) method with UV detection for the pharmacokinetic study of <z:chebi fb="0" ids="38747">taxifolin</z:chebi> in rabbit plasma after enzymatic hydrolysis was developed and validated for the first time </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="38747">Taxifolin</z:chebi>, with <z:chebi fb="0" ids="17574">biochanin A</z:chebi> as the internal standard, was extracted from plasma samples by liquid/liquid extraction after hydrolysis with beta-glucuronidase and sulfatase </plain></SENT>
<SENT sid="3" pm="."><plain>Chromatographic separation was conducted on a Luna C18 column (4.6 mm x 150 mm, 5 microm particle size) and pre-column (2.0 mm, the same sorbent) </plain></SENT>
<SENT sid="4" pm="."><plain>Two-step linear gradient elution with <z:chebi fb="0" ids="38472">acetonitrile</z:chebi> and 0.03% water solution of <z:chebi fb="0" ids="45892">trifluoroacetic acid</z:chebi> as mobile phase at a flow rate of 1.0 ml/min was used </plain></SENT>
<SENT sid="5" pm="."><plain>The UV detector is set at 290 nm </plain></SENT>
<SENT sid="6" pm="."><plain>The elution time for <z:chebi fb="0" ids="38747">taxifolin</z:chebi> and <z:chebi fb="0" ids="17574">biochanin A</z:chebi> was approximately 7.9 and 18.3 min, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The calibration curve of <z:chebi fb="0" ids="38747">taxifolin</z:chebi> was linear (r &gt; 0.9997) over the range of 0.03-5.0 microg/ml in rabbit plasma </plain></SENT>
<SENT sid="8" pm="."><plain>The limit of detection (LOD) and limit of quantification (LOQ) for <z:chebi fb="0" ids="38747">taxifolin</z:chebi> were 0.03 and 0.11 microg/ml, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The present method was successfully applied for the estimation of the pharmacokinetic parameters of <z:chebi fb="0" ids="38747">taxifolin</z:chebi> following intravenous and oral administration of <z:chebi fb="23" ids="18059">lipid</z:chebi> solution to rabbits </plain></SENT>
<SENT sid="10" pm="."><plain>The absolute bioavailability of <z:chebi fb="0" ids="38747">taxifolin</z:chebi> after oral administration of <z:chebi fb="23" ids="18059">lipid</z:chebi> solution was 36% </plain></SENT>
</text></document>